Trevena, Inc.
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TRVN Smart Score
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Show Less
Recent trades of TRVN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TRVN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to TRVN
Recent picks made for TRVN stock on CNBC
ETFs with the largest estimated holdings in TRVN
Flights by private jets registered to TRVN